Skip to main content
Vrajesh K. Pandya

Vrajesh K. Pandya, PhD

Languages spoken: English

Academic Information

Departments Primary - Pathology

Board Certification

  • American Board of Clinical Chemistry (Sub: Clinical Chemistry)

Education History

Undergraduate Gujarat University
BSc
Graduate Training Maharaja Sayajirao University of Baroda
MSc
Graduate Training University of Alberta
PhD
Postdoctoral Fellowship University of Alberta
Postdoctoral Fellow
Postdoctoral Fellowship University of Utah School of Medicine
Postdoctoral Fellow

Selected Publications

Journal Article

  1. Githaka JM, Tripathi N, Kirschenman R, Patel N, Pandya V, Kramer DA, Montpetit R, Zhu LF, Sonenberg N, Fahlman RP, Danial NN, Underhill DA, Goping I (2021). BAD regulates mammary gland morphogenesis by 4E-BP1-mediated control of localized translation in mouse and human models. Nature communications, 12(1), 2939.
  2. Salla M, Pandya V, Bhullar KS, Kerek E, Wong YF, Losch R, Ou J, Aldawsari FS, Velazquez-Martinez C, Thiesen A, Dyck JRB, Hubbard BP, Baksh (2020). Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs. Molecules (Basel, Switzerland), 25(17),
  3. Pandya V, Githaka JM, Patel N, Veldhoen R, Hugh J, Damaraju S, McMullen T, Mackey J, Goping I (2020). BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. Cell death & disease, 11(6), 448.
  4. Pandya V, Glubrecht D, Vos L, Hanson J, Damaraju S, Mackey J, Hugh J, Goping I (2016). The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Oncotarget, 7(22), 33272-85.
  5. Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velázquez-Martínez CA, Baksh (2018). Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis. The Journal of pharmacology and experimental therapeutics, 365(2), 354-367.
  6. Pandya V, Nguyen Sorenson AHT, Jones E, Young BA, Pearson L (2023). Spirited away: Can ethanol testing in add-on orders provide meaningful results?. Clinical biochemistry, 115, 97-102.
  7. Pandya V, Wilker C, McMillin G (2023). Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters. Journal of analytical toxicology, 47(1), 96-105.
  8. Pandya V, Wilker C, Johnson-Davis K (2023). Longitudinal trends in meconium drug detection in 46 US states between the years 2015-2020. Journal of analytical toxicology, 47(6), 495-503.
  9. Pandya V, McMillin GA, Young B (2023). Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing?. The journal of applied laboratory medicine, 8(2), 341-346.
  10. Mathewson NJ, Okoye NC, Nelson HA, Pandya V, Moore C, Johnson-Davis K (2025). Beyond the baseline: quantification of two phosphatidylethanol homologues in whole blood by LC-MS-MS and retrospective data analysis from a National Reference Laboratory. Journal of analytical toxicology, 49(3), 191-200.

Book Chapter

  1. Pandya V, Frank E (2022). A Simple, Fast, and Reliable LC-MS/MS Method for the Measurement of Homovanillic Acid and Vanillylmandelic Acid in Urine Specimens. Methods in molecular biology (Clifton, N.J.), 2546, 175-183.

Commentary

  1. Pandya (2023). Commentary on Unexpected Fentanyl Detection during a Liver Transplant Evaluation. Clinical chemistry, 69(3), 226-227.

Case Report

  1. Smith Z, Goyal P, Pandya V, Thakar CV, Gudsoorkar P (2023). Hyperuricemia in a patient with Waldenström’s Macroglobulinemia: An innocent bystander?. Journal of Onco-Nephrology, 7(2), 79-83.
  2. Pandya V, Hunsaker JJH, La'ulu SL, Genzen JR, Frank EL, Johnson LM, Rudolf J (2021). Excessively low cholesterol and triglyceride levels in an apparently healthy patient. Clinical biochemistry, 96, 78-81.
  3. Azim A, Hu B, Gilligan S, Sarwal A, Hartsell S, Pandya V, Raphael K (2024). How I Evaluate a High Anion Gap Metabolic Acidosis. Clinical journal of the American Society of Nephrology, 19(4), 525-527.
  4. Pandya V, Delgado J (2025). Hiding in Plain Sight: Protein Electrophoresis Profile Inconsistent with Patient's Diagnosis. Clinical chemistry, 71(2), 248-252.
  5. Mathewson NJ, Baryeh K, Rudolf JW, Sundaresh V, Pandya (2024). Alkaline Phosphatase Activity Inconsistent with Patient's Clinical Presentation: A Cautionary Tale. Clinical chemistry, 70(12), 1411-1414.

Letter

  1. Hunsaker JJH, La'ulu SL, Zupan E, Patel D, Pandya V, Rudolf J (2024). Detection of a High-Dose Hook Effect and Evaluation of Dilutions of Urine Myoglobin Specimens Using a Serum Myoglobin Assay. Annals of laboratory medicine, 44(4), 367-370.